Bitcoin’s (BTC) recovery is facing stiff resistance near $48,500, indicating that bears are active at higher levels.  By combining the popular stock-to-flow Bitcoin price model and the illiquid supply data, analyst William Clemente projects $39,000 to act as a strong floor on any declines. On the upside, analysts remain bullish. Bloomberg Intelligence chief analyst Mike
0 Comments
In this article TMO FANG X IVZ Moderna’s sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021. Boston Globe | Getty Images Check out the companies making headlines in midday trading. Thermo Fisher Scientific — The maker of scientific equipment saw shares jump more than 8.5% after it said earnings
0 Comments
If e-commerce is now just commerce, then ContextLogic (NASDAQ:WISH) stock is overvalued. Source: sdx15 / Shutterstock.com ContextLogic runs Wish.com. Wish is an online store that looks like China’s Pinduoduo (NASDAQ:PDD). It’s focused on creating impulse buys, on serendipity. It’s the kind of store that, in a shopping mall, you could spend hours in or walk
0 Comments
In this article REGN MSFT LVS WYNN WEBR CNR-CA Check out the companies making headlines before the bell: Weber (WEBR) – The grill maker’s stock jumped 3.8% in the premarket, following its first quarterly report since going public in August. Weber’s sales rose 19% from a year earlier, and the company projected full-year sales largely
0 Comments
A pharmaceutical play, Novavax (NASDAQ:NVAX) has been on the move. In fact, NVAX stock has risen nearly three times higher since November of last year. Source: Ascannio/Shutterstock.com This leap is primarily due to the company’s Covid-19 vaccine inching closer to commercial release. However, despite the price appreciation, I believe there is still plenty of upside
0 Comments
Increasing M&A deals and cutting edge therapies are driving biotech ETFs higher. IShares Nasdaq Biotechnology ETF: https://www.zacks.com/funds/etf/IBB/profile?cid=CS-YOUTUBE-FT-VID SPDR S&P Biotech ETF: https://www.zacks.com/funds/etf/XBI/profile?cid=CS-YOUTUBE-FT-VID ARK Genomic Revolution ETF: https://www.zacks.com/funds/etf/ARKG/profile?cid=CS-YOUTUBE-FT-VID Virtus LifeSci Biotech Clinical Trials ETF: https://www.zacks.com/funds/etf/BBC/profile?cid=CS-YOUTUBE-FT-VID ALPS Medical Breakthroughs ETF: https://www.zacks.com/funds/etf/SBIO/profile?cid=CS-YOUTUBE-FT-VID Merck: https://www.zacks.com/stock/quote/MRK?cid=CS-YOUTUBE-FT-VID Biogen: https://www.zacks.com/stock/quote/BIIB?cid=CS-YOUTUBE-FT-VID Sanofi: https://www.zacks.com/stock/quote/SNY?cid=CS-YOUTUBE-FT-VID ArQule: https://www.zacks.com/stock/quote/ARQL?cid=CS-YOUTUBE-FT-VID Synthorx: https://www.zacks.com/stock/quote/THOR?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow
0 Comments
This weekly roundup of news from Mainland China, Taiwan, and Hong Kong attempts to curate the industry’s most important news, including influential projects, changes in the regulatory landscape, and enterprise blockchain integrations. Regulatory noise In this week’s column, the Man in Shanghai is determined to squeeze all of the regulatory noise into one section, so
0 Comments